10-Q

Company

Xeris Biopharma Holdings, Inc.

Filed

May 11, 2022

Period of Report

March 31, 2022

Accession Number

0001867096-22-000063

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →